Skip to main content
Veterinary Medicines

Theranekron D6 - injekčný roztok pre zvieratá

Authorised
  • Tarentula cubensis D6

Product identification

Medicine name:
Theranekron D6 - injekčný roztok pre zvieratá
Active substance:
  • Tarentula cubensis D6
Target species:
  • Cattle
  • Horse
  • Pig
  • Sheep
  • Goat
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Tarentula cubensis D6
    1.00
    millilitre(s)
    /
    50.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Cattle
      • Meat and offal
        0
        day
    • Horse
      • Meat and offal
        0
        day
    • Pig
      • Meat and offal
        0
        day
    • Sheep
      • Meat and offal
        0
        day
    • Goat
      • Meat and offal
        0
        day
    • Dog
      • Not applicable
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QV03AX
Authorisation status:
  • Valid
Authorised in:
  • Slovakia
Available in:
  • Slovakia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Vetviva Richter GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Richter Pharma AG
Responsible authority:
  • Institute For State Control Of Veterinary Biologicals And Medicaments
Authorisation number:
  • 96/069/15-S
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Slovak (PDF)
Published on: 18/05/2023
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."